HARRISBURG – Prescription drug monitoring legislation has received the approval of the PA Senate Public Health and Welfare Committee. Senate Bill 1180 expands the state’s prescription drug monitoring program to include all drugs, up to and including Schedule V controlled substances. Currently, the state Attorney General houses a monitoring program with dispensing data for Schedule 2 controlled substances. Committee Chair, Cumberland County Sen. Pat Vance explained she introduced the measure for patient safety to keep people from addiction. She says prescription drugs like OxyContin andother drugs can lead to addiction and even death. To address some concerns, the bill was amended to limit data referral to law enforcement or a licensing board only in instances in which there is a pattern of irregular data, deviating from the clinical standard.